Thymic Neuroendocrine Tumors

Thoracic Surgery Clinics

Volumn 24, Issue 3, 2014, Pages 327-332

  Lausi, Paolo Olivo ^a   Refai, Majed ^b   Filosso, Pier Luigi ^a   Ruffini, Enrico ^a   Oliaro, Alberto ^a   Guerrera, Francesco ^a   Brunelli, Alessandro ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Neuroendocrine tumors; Outcome; Radiotherapy; Surgery; Thymus

Indexed keywords

ALPHA INTERFERON; CISPLATIN; SOMATOSTATIN DERIVATIVE; TEMOZOLOMIDE;

ADVANCED CANCER; CANCER PROGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ELECTRON MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MOLECULARLY TARGETED THERAPY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STERNOTOMY; THORACOTOMY; THYMIC NEUROENDOCRINE TUMOR; THYMOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; CHEMOTHERAPY; OUTCOME; RADIOTHERAPY; SURGERY; THYMUS;

CHEMOTHERAPY; NEUROENDOCRINE TUMORS; OUTCOME; RADIOTHERAPY; SURGERY; THYMUS;

HUMANS; NEUROENDOCRINE TUMORS; THYMOMA; THYMUS NEOPLASMS;

EID: 84907050953     PISSN: None     EISSN: 15585069     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2014.05.007     Document Type: Review

References (26)

1. Goto K., Kodama T., Matsuno Y., et al. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 2001, 14:985-994.
2. Chaer R., Massad M.G., Evans A., et al. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002, 74:1733-1740.
3. Gaur P., Leary C., Yao J.C. Thymic neuroendocrine tumors: a SEER database analysis of 160 patients. Ann Surg 2010, 251:1117-1121.
4. Teh B.T., McArdle J., Chan S.P., et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore) 1997, 76:21-29.
5. Gibril F., Chen Y.J., Schrump D.S., et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003, 88:1066-1081.
6. Ferolla P., Falchetti A., Filosso P., et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90:2603-2609.
7. Goudet P., Bonithon-Kopp C., Murat A., et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol 2011, 165(1):97-105.
8. Wick M.R., Rosai J. Neuroendocrine neoplasms of the thymus. Pathol Res Pract 1988, 183:188-199.
9. de Montpréville V., Macchiarini P., Dulmet E. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 1996, 111:134-141.
10. Moran C.A., Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus: a clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000, 114:100-110.
11. Phan A.T., Oberg K., Choi J., et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas 2010, 39(6):784-798.
12. Mizuno T., Masaoka A., Hashimoto T., et al. Coexisting thymic carcinoid tumor and thymoma. Ann Thorac Surg 1990, 50:650-652.
13. Moran C.A., Suster S., Fishback N., et al. Mediastinal paragangliomas: a clinicopathologic and immunohistochemical study of 16 cases. Cancer 1993, 72:2358-2364.
14. Rosai J., Higa E. Mediastinal endocrine neoplasm of probable thymic origin related to carcinoid tumor. Cancer 1972, 29:1061-1074.
15. Kay S., Willson M.A. Ultrastructural studies of an ACTH secreting thymic tumor. Cancer 1970, 26:445-452.
16. Duguid J.B., Kennedy A.M. Oat-cell tumours of mediastinal glands. J Pathol 1930, 23:93-99.
17. Wick M.R., Scheithauer B.W. Oat-cell carcinoma of the thymus. Cancer 1982, 49:1652-1657.
18. Wick M., Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol 1991, 8:35-51.
19. Marx A., Shimosato Y., Kuo T.T., et al. Thymic neuroendocrine tumours. Pathology & genetics: tumours of the lung, pleura, thymus and heart 2004, 188-195. IARC Press, Lyon (France). W.D. Travis, E. Brambilla, H.K. Muller-Hermelink (Eds.).
20. Ho F., Ho J. Pigmented carcinoid tumour of the thymus. Histopathology 1977, 1:363-369.
21. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Ann Oncol 2001, 12:S111-S114.
22. Hamada S., Masago K., Mio T., et al. Good clinical response to imatinib mesylate in atypical thymic carcinoid with KIT overexpression. J Clin Oncol 2011, 29:e9-e10.
23. Ekeblad S., Sundin A., Janson E.T., et al. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin Cancer Res 2007, 13:2986-2991.
24. van Essen M., Krenning E.P., Bakker W.H., et al. Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumors of bronchial, gastric and thymic origin. Eur J Nucl Med Mol Imaging 2007, 34(8):1219-1227.
25. Filosso P.L., Actis Dato G.M., Ruffini E., et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg 2004, 127:1215-1219.
26. Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg 2003, 76:878-884.